ERAS Erasca, Inc.
Nasdaq · SEC CIK 1761918 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.28M 3 sales by 2 insiders
- Filings on record
- 109 since 2021-07-20, latest 2026-08-12 16:22
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Garner Ebun | GC, Corp. Sec | — | $1.98M |
| Morris Shannon | Chief Medical Off | — | $300.8K |
| Chacko David M. | CFO, CBO | — | — |
Transactions 48
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-03 09:00 | 2026-04-01 | ERAS | Garner Ebun | CLO | M - OptEx | $1.70 | +80.0K | 105.1K | +319% | +$136.0K |
| DT | 2026-04-03 09:00 | 2026-04-01 | ERAS | Garner Ebun | CLO | S - Sale+OE | $16.40 | -80.0K | 25.1K | -76% | -$1.31M |
| DT | 2026-03-06 | 2026-03-04 | ERAS | Morris Shannon | Chief Medical Off | S - Sale+OE | $15.04 | -20.0K | 0 | -100% | -$300.8K |
| DT | 2026-03-06 | 2026-03-04 | ERAS | Morris Shannon | Chief Medical Off | M - OptEx | $1.70 | +20.0K | 20.0K | New | +$34.0K |
| D | 2026-01-30 | 2025-12-15 | ERAS | Chacko David M. | CFO, CBO | J - Other | $1.19 | +17.8K | 280.0K | +7% | +$21.2K |
| DT | 2026-01-08 | 2025-12-15 | ERAS | Garner Ebun | GC, Corp. Sec | A - Grant | $1.19 | +3,902 | 25.1K | +18% | +$4,643 |
| DT | 2026-01-08 | 2026-01-07 | ERAS | Garner Ebun | GC, Corp. Sec | S - Sale+OE | $5.59 | -120.0K | 25.1K | -83% | -$670.8K |
| DT | 2026-01-08 | 2026-01-07 | ERAS | Garner Ebun | GC, Corp. Sec | M - OptEx | $1.70 | +120.0K | 145.1K | +479% | +$204.0K |
| I | 2025-06-03 | 2025-05-23 | ERAS | Multani Pratik S | Dir | G - Gift | $0.00 | +6,200 | 6,200 | New | $0 |
| 2025-06-03 | 2025-05-23 | ERAS | Multani Pratik S | Dir | G - Gift | $0.00 | -6,200 | 166.7K | -4% | $0 | |
| DM | 2025-02-05 | 2024-06-14+ | ERAS | Garner Ebun | GC, Corp. Sec | J - Other | $1.56 | +11.4K | 21.2K | +118% | +$17.9K |
| DM | 2025-02-05 | 2024-06-14+ | ERAS | Chacko David M. | CFO, CBO | J - Other | $1.56 | +15.5K | 262.2K | +6% | +$24.1K |
| 2024-05-22 | 2024-05-21 | ERAS | Casdin Alexander W. | Dir | P - Purchase | $2.27 | +80.0K | 574.0K | +16% | +$181.6K | |
| 2023-12-18 | 2023-12-15 | ERAS | Garner Ebun | GC, Corp. Sec | J - Other | $1.59 | +5,448 | 9,728 | +127% | +$8,662 | |
| 2023-12-18 | 2023-12-15 | ERAS | Chacko David M. | CFO, CBO | J - Other | $1.59 | +7,478 | 246.7K | +3% | +$11.9K | |
| I | 2023-12-08 | 2023-12-06 | ERAS | Start Valerie Denise Harding | Dir | P - Purchase | $1.85 | +10.0K | 20.0K | +100% | +$18.5K |
| MI | 2023-12-06 | 2023-12-05+ | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $1.70 | +1.00M | 12.90M | +8% | +$1.70M |
| 2023-12-04 | 2023-12-04 | ERAS | Casdin Alexander W. | Dir | P - Purchase | $1.66 | +30.0K | 494.0K | +6% | +$49.8K | |
| I | 2023-10-10 | 2023-10-05 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.03 | +1.00M | 19.46M | +5% | +$2.03M |
| I | 2023-06-08 | 2023-06-08 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.75 | +100.0K | 18.40M | +0.5% | +$275.0K |
| 2023-04-11 | 2023-04-10 | ERAS | Casdin Alexander W. | Dir | P - Purchase | $2.76 | +20.0K | 464.0K | +5% | +$55.2K | |
| I | 2023-03-28 | 2023-03-28 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $2.84 | +100.0K | 18.30M | +0.5% | +$284.0K |
| DM | 2023-02-03 | 2023-02-01 | ERAS | Chacko David M. | CFO | J - Other | $4.10 | +1,750 | 239.2K | +0.7% | +$7,175 |
| DM | 2023-02-03 | 2023-02-01 | ERAS | Wei Lin | Chief Medical Off | J - Other | $4.10 | +1,750 | 315.8K | +0.6% | +$7,175 |
| DM | 2023-02-03 | 2023-02-01 | ERAS | Garner Ebun | GC, Corp. Sec | J - Other | $4.10 | +2,390 | 4,280 | +126% | +$9,799 |
| I | 2023-01-10 | 2023-01-10 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $3.86 | +60.0K | 20.26M | +0.3% | +$231.6K |
| I | 2022-12-22 | 2022-12-21 | ERAS | Bristol James Arthur | Dir | P - Purchase | $4.14 | +20.0K | 20.0K | New | +$82.8K |
| I | 2022-12-22 | 2022-12-21 | ERAS | Start Valerie Denise Harding | Dir | P - Purchase | $4.64 | +10.0K | 10.0K | New | +$46.4K |
| AI | 2022-12-21 | 2022-12-13 | ERAS | Cormorant Asset Management, LP | Dir | P - Purchase | $6.50 | +307.7K | 10.81M | +3% | +$2.00M |
| I | 2022-12-20 | 2022-12-13 | ERAS | Cormorant Asset Management, LP | Dir | P - Purchase | $6.50 | +307.7K | 10.81M | +3% | +$2.00M |
| 2022-12-15 | 2022-12-15 | ERAS | Casdin Alexander W. | Dir | P - Purchase | $4.87 | +20.0K | 444.0K | +5% | +$97.4K | |
| I | 2022-12-15 | 2022-12-14 | ERAS | Lim Jonathan E | COB, CEO, Dir, 10% | P - Purchase | $4.99 | +40.0K | 20.20M | +0.2% | +$199.6K |
| I | 2022-07-06 | 2022-07-01 | ERAS | Casdin Alexander W. | Dir | J - Other | $0.00 | -750.0K | 0 | -100% | $0 |
| D | 2022-02-03 | 2022-02-01 | ERAS | Garner Ebun | GC, Corp. Sec | J - Other | $11.60 | +990 | 1,890 | +110% | +$11.5K |
| D | 2022-02-03 | 2022-02-01 | ERAS | Chacko David M. | CFO | J - Other | $11.60 | +1,562 | 237.5K | +0.7% | +$18.1K |
| D | 2022-02-03 | 2022-02-01 | ERAS | Wei Lin | Chief Medical Off | J - Other | $11.60 | +1,562 | 314.1K | +0.5% | +$18.1K |
| I | 2021-08-10 | 2021-08-10 | ERAS | Chen Bihua | Dir | P - Purchase | $22.10 | +200.0K | 10.51M | +2% | +$4.42M |
| I | 2021-08-10 | 2021-07-26 | ERAS | Chen Bihua | Dir | S - Sale | $18.77 | -200.0K | 10.31M | -2% | -$3.75M |
| DI | 2021-07-22 | 2021-07-20 | ERAS | Cormorant Asset Management, LP | 10% | C - Cnv Deriv | — | +9.56M | 9.56M | New | — |
| DI | 2021-07-22 | 2021-07-20 | ERAS | Cormorant Asset Management, LP | 10% | P - Purchase | $16.00 | +950.0K | 10.51M | +10% | +$15.20M |
| 2021-07-20 | 2021-07-20 | ERAS | Garner Ebun | GC | P - Purchase | $16.00 | +900 | 900 | New | +$14.4K | |
| DMI | 2021-07-20 | 2021-07-20 | ERAS | City Hill, LLC | 10% | C - Cnv Deriv | — | +10.58M | 20.16M | +110% | — |
| 2021-07-20 | 2021-07-20 | ERAS | Hambleton Julie | Dir | P - Purchase | $16.00 | +6,000 | 6,000 | New | +$96.0K | |
| 2021-07-20 | 2021-07-20 | ERAS | Multani Pratik S | Dir | P - Purchase | $16.00 | +6,200 | 172.9K | +4% | +$99.2K | |
| 2021-07-20 | 2021-07-20 | ERAS | Start Valerie Denise Harding | Dir | P - Purchase | $16.00 | +2,000 | 2,000 | New | +$32.0K | |
| DMI | 2021-07-20 | 2021-07-20 | ERAS | Burow Kristina | 10% | C - Cnv Deriv | — | +11.06M | 5.53M | New | — |
| DI | 2021-07-20 | 2021-07-20 | ERAS | Casdin Alexander W. | Dir | C - Cnv Deriv | — | +750.0K | 750.0K | New | — |
| D | 2021-07-20 | 2021-07-20 | ERAS | Casdin Alexander W. | Dir | C - Cnv Deriv | — | +150.0K | 337.5K | +80% | — |
Purchase Sale Sale after option exercise All abbreviations